The emergence of psychotic experiences in the early adolescence of 22q11.2 Deletion Syndrome by Chawner, Samuel J.R.A. et al.
Contents lists available at ScienceDirect
Journal of Psychiatric Research
journal homepage: www.elsevier.com/locate/jpsychires
The emergence of psychotic experiences in the early adolescence of 22q11.2
Deletion Syndrome
Samuel J.R.A. Chawner, Maria Niarchou, Joanne L. Doherty, Hayley Moss, Michael J. Owen,
Marianne B.M. van den Bree∗
Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiﬀ University, Cardiﬀ,
Wales, United Kingdom
A R T I C L E I N F O
Keywords:
Schizophrenia
Genetics
Neurocognition
A B S T R A C T
Individuals with 22q11.2 Deletion Syndrome (22q11.2DS) are at substantial increased risk of psychosis spectrum
outcomes including schizophrenia. We conducted a prospective, longitudinal study of the psychopathological
and neurocognitive correlates of early psychotic phenomena in young people with 22q11.2DS (n= 75, mean age
time 1 (T1) 9.9 years, time 2 (T2) 12.5 years). We also assessed unaﬀected control siblings (n=33, mean age T1
10.6 years, T2 13.4 years). The prevalence of psychotic experiences, deﬁned as subthreshold psychotic phe-
nomena, substantially increased in children with 22q11.2DS from 4% (n=3) in childhood (T1) to 21% (n=16)
in early adolescence (T2) (p= 0.001), and at T2 prevalence was signiﬁcantly elevated (p= 0.020) relative to
control siblings (3%). The emergence of psychotic experiences was associated with levels of childhood anxiety
symptoms at T1 and diﬀerential development of the attention-executive domain. IQ ability and IQ change,
however, were not associated with the emergence of psychotic experiences, indicating that initial changes in
attention-executive functioning may precede the decline in global cognition that has been reported to be as-
sociated with later stages of psychosis development. Our study highlights that psychotic phenomena emerge
early in 22q11.2DS and we implicate attention-executive functioning and anxiety as key domains associated
with the development of these psychotic experiences.
1. Introduction
Identifying the early antecedents of psychotic disorders is vital for
understanding aetiology and informing potential interventions, but
does however provide a challenge for researchers. Studies of individuals
at clinical high-risk of psychosis, although insightful, capture the end
phases of the disease process and are unable to assess earlier premorbid
phases. Large cohort studies of the general population have provided
insights into the childhood antecedents of psychosis. Children who
develop schizophrenia in adulthood have deﬁcits from a young age in
verbal reasoning and as they get older they increasingly lag behind
their peers in working memory, attention, and processing speed
(Reichenberg et al., 2010). However, given the prevalence of psychosis
in the general population (2.3–3.5%) (Perälä et al., 2007; van Os and
Kapur, 2009), the number of individuals who develop psychosis in
cohort studies is small. Studies of high-risk groups, where a high pro-
portion of young people will develop psychotic spectrum outcomes,
represents an eﬀective methodology, as individuals can be tracked
through the period of increasing psychosis risk.
22q11.2 Deletion Syndrome (22q11.2DS) is one of the strongest risk
factors for the development of psychosis, with 30–40% of adults de-
veloping psychotic disorder (Monks et al., 2014; Murphy et al., 1999;
Schneider et al., 2014). 22q11.2DS aﬀects 1 in 4000 live births and the
associated phenotype is highly variable including congenital abnorm-
alities, developmental delay and high rates of psychiatric morbidity
across the lifespan (Hiroi et al., 2013; Niarchou et al., 2014; Schneider
et al., 2014). Furthermore, the psychosis spectrum phenotype is com-
parable to that of individuals without the deletion (Bassett et al., 2003;
Monks et al., 2014; Tang et al., 2017). Prospective assessment of in-
dividuals with 22q11.2DS therefore oﬀers a powerful approach for
exploring the early antecedents of psychosis (Gur et al., 2017), parti-
cularly earlier stages of psychosis development before individuals meet
clinical high-risk criteria and assessment is unbiased by retrospective
recall, antipsychotic medication use or the eﬀects of psychosis on the
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brain. Understanding of these earlier stages will be important for de-
veloping very early interventions for psychosis.
Several important insights have arisen from prospective long-
itudinal studies of children with 22q11.2DS. First, as found in general
population studies (Van Os et al., 2000), psychotic features are present
on a continuum in individuals with 22q11.2DS (Baker and Skuse, 2005;
Weisman et al., 2017) and are predictive of development of later psy-
chotic disorder (Gothelf et al., 2007a; Schneider et al., 2016). Second,
longitudinal studies of individuals with 22q11.2DS have found several
domains of psychopathology to be associated with psychosis develop-
ment, including childhood anxiety (Gothelf, Feinstein, 2007a;
Schonherz et al., 2014). Third, cognitive development has been asso-
ciated with psychosis risk in 22q11.2DS, with verbal IQ (VIQ) in par-
ticular being implicated (Gothelf et al., 2007b, 2013; Vorstman et al.,
2015). Although an under-researched area, the importance of broadly
assessing cognition has been recognised. Cognitive ﬂexibility, emotion
recognition and reading decoding have been identiﬁed as predictors of
psychosis development in 22q11.2DS (Antshel et al., 2016), and the
authors hypothesised that these neurocognitive changes may be pri-
mary and contribute to VIQ decline reported in 22q11.2DS. Fourth, it
has been hypothesised that individuals who exhibit cognitive dete-
rioration are particularly at risk of psychosis (Swillen and McDonald-
McGinn, 2015). Cognitive deterioration has been reported in children
in 22q11.2DS (Duijﬀ et al., 2012, 2013), but may not be speciﬁc to the
syndrome (Chawner et al., 2017).
Longitudinal studies of 22q11.2DS investigating neurocognitive
predictors of psychosis spectrum outcomes to date have focused on late
adolescence and early adulthood (see (Tang and Gur, 2017) for a
comprehensive review of studies). These periods are very informative
for understanding the latter stages of psychosis development and fac-
tors predictive of transitioning from high risk-states to psychosis,
however, a gap remains in the literature covering earlier periods. There
is evidence that early adolescence represents a crucial period, with a
large international study of 22q11.2DS reporting that VIQ trajectories
of those who later develop psychosis began to diverge from age 11
(Vorstman et al., 2015). Only one longitudinal study has examined
neurocognitive and psychopathology domains across this period, as-
sessing children with 22q11.2DS at a mean age of 10 years and then at
13.5 years, and found that baseline IQ predicted later psychotic out-
comes (Hooper et al., 2013). However, the authors acknowledge that
their sample size was small (n= 42) and that this important period
warrants further study. Identifying factors associated with the emer-
gence of very early psychotic phenomena could potentially uncover the
initial processes important in psychosis development, without risk of
confounding by disease progression. Although early phenomena such as
psychotic experiences are transient across adolescence (Niarchou et al.,
2015), they do have good short term test-retest reliability (Ronald et al.,
2013) and are predictive of adult psychotic disorder in the general
population (5- to 16-fold increased risk) (Hanssen et al., 2005; Poulton
et al., 2000). It has been argued that schizophrenia and psychotic dis-
orders should be viewed as cognitive illnesses (Kahn and Keefe, 2013),
whereby cognitive decline emerges years before the onset of the ﬁrst
psychotic episode (Fuller et al., 2002) and that characterisation of this
initial cognitive change is important for diagnosis and understanding
aetiology. Examining the neurocognitive factors associated with the
emergence of early psychotic phenomena in 22q11.2DS is a unique
opportunity to explore this.
2. Aims of the study
This study presents ﬁndings from the Cardiﬀ University ECHO
(Experiences of CHildren with cOpy number variants) study long-
itudinal cohort of children with 22q11.2DS and their unaﬀected sibling
controls. We have previously reported on cognitive development in this
cohort (Chawner et al., 2017), here we focus on the emergence of early
psychosis-spectrum outcomes. Our hypotheses were 1) the prevalence
of subthreshold psychotic phenomena would increase across early
adolescence in children with 22q11.2DS and 2) that the level of im-
pairment and developmental change in speciﬁc neurocognitive and
psychiatric domains would be associated with the emergence of sub-
threshold psychotic phenomena in children with 22q11.2DS. In parti-
cular, childhood anxiety and development of IQ and executive functions
have been previously implicated in the development of psychosis-
spectrum outcomes in 22q11.2DS (Tang and Gur, 2017) and the general
population (Hall, 2017; Mollon et al., 2018). In light of the limitations
of previous studies, we utilised the same measures in cases and controls
at both time points, examined cognitive domains beyond IQ, and we
also investigated whether individuals who exhibited cognitive dete-
rioration were at increased risk of developing psychotic phenomena.
3. Methodology
3.1. Participants
This investigation was based on the ongoing Cardiﬀ longitudinal
ECHO study. 75 children with 22q11.2DS (mean age in years (SD), time
1 (T1)= 9.9 (2.4); time 2 (T2)= 12.5(2.3), 44 (59%) male) and 33
sibling controls closest in age to the index child (mean (SD), T1= 10.6
(2.0), T2= 13.4(2.0), 17 (52%) male) were assessed and thus the study
captures the developmental stage of early adolescence. The gap be-
tween T1 and T2 is 2.7 (SD=0.5) years. T1 and T2 age did not diﬀer
between 22q11.2DS and controls (independent t-test; T1 p=0.150, T2
p=0.060). At T1 participants with the deletion were recruited through
National Health Service (NHS) medical genetics clinics in the UK,
British 22q11.2DS charities Max Appeal and the 22Crew, and rare
chromosomal disorder support group Unique. Informed consent was
gained from primary carers and participants. Protocols were approved
by the NHS Wales Research Ethics Committee. Presence of the 22q11.2
deletion was conﬁrmed via medical genetics clinics and the Division of
Psychological Medicine and Clinical Neurosciences laboratory.
3.2. Longitudinal assessment
3.2.1. Neurocognitive assessment
To allow comparison of cognitive performance across domains and
between individuals, age-adjusted z-scores were derived using norms
available for each measure (CANTAB, 2006; Heaton et al., 1993;
Wechsler, 1999). Scores were constructed so that a negative score de-
noted a poorer outcome.
IQ was assessed using the Wechsler Abbreviated Scale of
Intelligence (WASI) (Wechsler, 1999), from which Full Scale IQ (FSIQ),
Verbal IQ (VIQ) and Performance IQ (PIQ) were derived. These scores
are already age-adjusted, subtest age-adjusted scores were derived as
well.
Speciﬁc neurocognitive domains were assessed using the Wisconsin
Card Sorting Test (WCST) (Heaton et al., 1993) where number of per-
severative errors measured the set-shifting ability aspect of executive
function. Furthermore the following CANTAB (Cambridge Neu-
ropsychological Test Automated Battery) (CANTAB, 2006) tests were
administered: spatial working memory (SWM) an executive function
task; stockings of Cambridge (SOC) which measured spatial planning
and is an executive function task; ﬁve choice reaction time (RTI) which
measured processing speed; match-to-sample task (MTS) a test of visual
attention; and rapid visual information processing (RVP) a measure of
sustained attention. For MTS, only raw scores were used because there
are no CANTAB norms for this task.
3.3. Psychiatric assessment
3.3.1. Psychosis assessment
We assessed psychosis-spectrum-outcomes using the psychosis sec-
tion of the Child and Adolescent Psychiatric Assessment (CAPA)
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(Angold et al., 1995) that probes for the presence of psychotic disorders
and broader subthreshold phenomena, which we have termed “psy-
chotic experiences”. This measure is especially designed to be a child
friendly measure of subthreshold psychotic phenomena and has been
successfully administered by a previous study of children with
22q11.2DS (Baker and Skuse, 2005). Both primary carer and child re-
port interviews were conducted. In this section, initial screening ques-
tions probed for any evidence of perceptual disorders or hallucinations,
delusions, or psychotic abnormalities of thought processes. If partici-
pants scored on the screening questions, the interviewer continued with
more detailed probing about the nature of possible experiences. Ques-
tions were asked about the content and location of auditory, olfactory
and tactile hallucinations, thought insertion and broadcast, thought
echo and withdrawal and delusional thinking. Phenomena were coded
in a binary fashion (present/not present), this follows the same ap-
proach as a previous study (Baker and Skuse, 2005).
Stringent criteria were applied: a) psychotic experiences were only
coded as present if a detailed account of a speciﬁc example could be
recalled; b) the experience had occurred in the last three months; c) the
participant could describe how regularly the experience occurred; d) it
was clear to the interviewer that there weren't alternative explanations,
phenomena not coded as psychotic experiences included hypnagogic/
pompic hallucinations, eidetic imagery, elaborated fantasies, phe-
nomena consistent with the cultural and religious beliefs of the in-
dividual's family and peer group, imaginary companions, illusions,
hallucinations occurring as part of a seizure or clouded sensorium,
spots/stripes before the eyes and sensory changes associated with
headaches; e) there had to be agreement by two trained psychologists
on the ﬁnal coding of the audio recorded interview, complex cases were
discussed with a consultant child and adolescent psychiatrist. DSM
criteria of psychotic disorders were applied to determine whether
psychotic phenomena met disorder criteria. In analysis, psychotic ex-
periences were counted as present if reported by either the primary
carer or child.
3.4. Assessment of childhood psychiatric disorder
Autism Spectrum Disorder (ASD) traits were screened using the
Social Communication Questionnaire (SCQ) (Rutter et al., 2003), which
was completed by the primary carer. Total scores can range from 0 to
39. In our analysis we used the recommended (Berument et al., 1999)
score of 15 or higher as indicating putative ASD.
Psychiatric symptomatology (non-ASD), during the last 3 months
was assessed at both times using the CAPA by means of semi-structured
interview with the primary carer (parent CAPA). Children aged
11 + completed a self-report semi-structured interview on anxiety and
mood (child CAPA). Criteria were applied to establish DSM-IV-TR
(American Psychiatric Association, 2000) diagnosis and symptom
counts. All interviews were audio recorded and monitored by a con-
sultant child and adolescent psychiatrist. Diagnoses were reached by
consensus between two trained psychologists, in cases of disagreement
the case was discussed with a consultant child and adolescent psy-
chiatrist.
Individuals were classiﬁed as having any psychiatric disorder if they
met criteria on either the SCQ or CAPA. For any psychiatric disorder
symptom count we added the total CAPA symptom count to the SCQ
total score.
4. Statistical analysis
4.1. Aim 1: longitudinal development of psychiatric disorder and psychotic
experiences
For both individuals with 22q11.2DS and sibling controls pre-
valence and 95% conﬁdence intervals were calculated for each diag-
nosis. Within each group McNemar's test was conducted to investigate
whether prevalence of psychiatric diagnosis and psychotic experiences
changed across the two time points. At each time point, Fisher's exact
test was conducted to investigate whether prevalence diﬀered between
individuals with 22q11.2DS and unaﬀected sibling controls.
4.2. Aim 2: identify factors associated with the emergence of psychotic
experiences
Within children with 22q11.2DS we examined whether the presence
of psychotic experiences at T2 was associated with the following de-
mographics: age using an independent t-test; gender, 22q11.2DS origin
(de novo or inherited) and ethnicity using Fisher's exact test; household
income and maternal education using Mann-Whitney U tests.
Three children with 22q11.2DS who had psychotic experiences at
T1 were excluded from the following analysis to focus on neurocogni-
tive and psychiatric factors associated speciﬁcally with the emergence of
psychotic experiences.
4.2.1. Neurocognitive factors associated with the emergence of psychotic
experiences in 22q11.2DS
We investigated whether the presence of psychotic experiences at
T2 was associated with cognitive deﬁcits at T1 and T2. Cognitive dif-
ference was quantiﬁed by subtracting z-scores based on age standar-
dised cognitive performance between those who had psychotic experi-
ences at T2 but not T1 (PE(+)) and those who did not have psychotic
experiences at T1 and T2 (PE(-)). To examine whether average cogni-
tive ability and/or change in cognition were related to the emergence of
psychotic experiences we ﬁrst used a Principal Components Analysis
approach on 22q11.2DS test-retest age-adjusted cognitive scores, an
approach used previously identifying predictors of idiopathic psychotic
experiences (Niarchou et al., 2013). This identiﬁed two factors saverage
and schange where saverage represents the average cognitive performance
across both time points (childhood and early adolescence) and schange
cognitive change between childhood and adolescence. This method
allows for the examination of change without being inﬂuenced by mean
performance at either T1 or T2 (Niarchou et al., 2013) and avoiding the
issue of mathematical coupling. Logistic regression analysis was con-
ducted for each cognitive measure, with saverage, schange components as
predictors and the presence of psychotic experiences as the outcome.
We also examined whether cognitive deterioration was linked to the
emergence of psychotic experiences. Following previous literature, we
deﬁned cognitive deterioration as a decrease in raw score between T1
and T2 (Duijﬀ et al., 2012). We then investigated, using logistic re-
gression analysis for each measure, whether cognitive deterioration was
associated with the emergence of psychotic experiences at T2.
4.2.2. Psychiatric factors associated with the emergence of psychotic
experiences in 22q11.2DS
To test if T1 and T2 psychiatric diagnosis was associated with the
emergence of psychotic experiences at T2, Fisher's exact test was con-
ducted. We investigated if symptom count at T1 or T2 diﬀered in those
who developed psychotic experiences at T2 using Mann Whitney U-
tests. The Principal Components Analysis framework for cognitive
scores was applied to psychiatric symptom counts to test for associa-
tions between saverage, schange components and psychotic experiences.
Analysis was restricted to those psychiatric features previously found to
be signiﬁcantly more prevalent in children with 22q11.2DS relative to
control siblings in the ECHO cohort (Niarchou et al., 2014): any psy-
chiatric disorder (measured by CAPA and SCQ, excluding psychotic
disorders and experiences), any non-ASD disorder (measured by CAPA,
excluding psychotic disorders and experiences), anxiety disorder,
ADHD, ODD, and putative ASD (measured by SCQ).
4.3. Statistical correction
Signiﬁcance thresholds were derived by applying a Bonferroni
S.J.R.A. Chawner et al. Journal of Psychiatric Research 109 (2019) 10–17
12
correction for the number of principal components with eigenva-
lues> 1 derived from T1 and T2 variables. This PCA based method
takes into account that variables are not independent of each other due
to repeated measures, correlation between cognitive and psychiatric
scores, and mathematically related variables i.e. composite scores such
as IQ and total symptom count are mathematically related to the sub-
domain scores that comprise them. For aim 1 the signiﬁcance threshold
was set at p≤ 0.005; all results greater than 0.005 and less than 0.05
were considered nominally signiﬁcant. For aim 2 the signiﬁcance
threshold was set at p≤ 0.0045; all results greater than 0.0045 and less
than 0.05 were considered nominally signiﬁcant.
5. Results
5.1. Aim 1: psychiatric features across early adolescence
There was signiﬁcant psychiatric morbidity in individuals with
22q11.2DS relative to control siblings (see Table 1, Fig. 1). At both time
points prevalence of any psychiatric disorder, any non-ASD diagnosis,
any anxiety disorder, ADHD and putative ASD diagnosis were elevated
in 22q11.2DS. Regarding speciﬁc anxiety disorders, children with
22q112.DS had higher rates of generalised anxiety disorder at T2 and of
speciﬁc and social phobia at T1, compared to control siblings. None of
the children (22q11.2DS or controls) met criteria for schizophrenia or
other psychotic disorders at T1 or T2. However, the prevalence of
psychotic experiences increased in 22q11.2DS from 4% (n=3) at T1 to
21% (n=16) at T2 (McNemar's p= 0.001). Prevalence of psychotic
experiences was elevated at T2 in children with 22q11.2DS relative to
control siblings (21% vs 3%, Fisher's p= 0.020), but not at T1 (4% vs
3%, Fisher's p= 0.999). At T2 children with 22q11.2DS reported a
broad range of phenomena, including hallucinations across a range of
sensory modalities; broader perceptual phenomena such as derealisa-
tion, depersonalisation, jamais vu and altered perception of time; as
well as delusions and abnormalities of thought processes. The majority
of experiences reported at T2 were by the children (15 out of 16 cases),
in only 2 out of 16 cases did caregivers report psychotic experiences in
their children. The increase in psychotic experiences in children with
22q11.2DS from T1 to T2 was particularly driven by an increase in
hallucinations from 2.7% (n=2) to 16.0% (n=12) (McNemar's
p= 0.010), speciﬁcally tactile hallucinations 0.0% (n= 0) to 8.0%
(n= 6) (McNemar's p= 0.041) (Supplementary Table 1).
Prevalence of ADHD decreased from 37% (n=28) at T1 to 21%
(n= 16) at T2 in children with 22q11.2DS (McNemar's p= 0.004)
(Table 1).
Level of medication use (5.3%, 4/75 children with 22q11.2DS) was
low and had little eﬀect on longitudinal change in diagnosis and the
emergence of psychotic experiences (see Supplementary Materials),
therefore medication was not taken into consideration in analyses.
5.2. Aim 2: factors associated with the emergence of psychotic experiences
Children with and without psychotic experiences as reported at T2
did not diﬀer in terms of age, gender, 22q11.2DS inheritance, ethnicity,
household income and maternal education and therefore these demo-
graphic variables were not included as covariates in subsequent ana-
lyses. All psychiatric and cognitive domains correlated positively with
one another across T1 and T2 indicating that all scores had test-retest
reliability (Supplementary Table 2), thus supporting the examination of
change over time (Lowe and Rabbitt, 1998), as well as the analysis of
level of impairment, in relation to the development of psychotic ex-
periences.
5.3. Cognition
Cognitive scores were only included if the child understood the
task's instructions, therefore missingness was variable across neuro-
cognitive measures (Supplementary Table 3). Mean performance in IQ
combined for T1 and T2 (saverage) and change in IQ (schange) were not
associated with the emergence of psychotic experiences
(Supplementary Table 3). Mean performance on spatial working
memory combined for T1 and T2 (saverage) was negatively associated
(OR= 0.47, p = 0.034) with the emergence of psychotic experiences at
Table 1
Psychiatric disorder in 22q11.2DS and unaﬀected sibling controls at T1 and T2. Bold indicates p < 0.05 Any Psychiatric Disorder includes ASD screening. Values for
columns 7 and 13 are McNemar p-values and indicate whether there was a signiﬁcant change in prevalence between time points. Values for columns 14 and 15
represent Fisher's Exact p-values and indicate whether prevalence in children with 22q11.2DS signiﬁcantly diﬀered from controls.
22q11.2DS Controls Prevalence diﬀerence 22q11.2DS vs
Controls
n T1%(n) 95%CI T2%(n) 95%CI p n T1%(n) 95%CI T2%(n) 95%CI p T1 p T2 p
Any Psychiatric Disorder 69 59% (41) 48,71 59% (41) 48,71 0.999 30 7% (2) −3,2 7% (2) −3,2 0.999 < 0.001 <0.001
Any Non-ASD Psychiatric
Disorder
75 53% (40) 42, 65 48% (36) 36, 60 0.454 33 9% (3) −1, 19 9% (3) −1, 19 0.999 < 0.001 <0.001
Any Anxiety Disorder 75 35% (26) 24, 46 27% (20) 16, 37 0.238 33 0% (0) – 6% (2) −3, 15 0.500 < 0.001 0.018
Agoraphobia 8% (6) 2, 14 11% (8) 4, 18 0.727 0% (0) – 0% (0) – – 0.174 0.103
Generalised Anxiety Disorder 8% (6) 2, 14 16% (12) 8, 24 0.070 0% (0) – 0% (0) – – 0.174 0.016
OCD 3% (2) −1, 6 0% (0) – 0.500 0% (0) – 0% (0) – – 0.999 –
Panic Disorder 3% (2) −1, 6 3% (2) −1, 6 0.999 0% (0) 7% (2) 1, 12 – 0.999 0.999
Separation Anxiety Disorder 5% (4) 0, 11 7% (5) 1, 12 0.999 0% (0) – 0% (0) – – 0.311 0.320
Speciﬁc Phobia 17% (13) 9, 26 9% (7) 3, 16 0.070 0% (0) – 3% (1) −3, 9 0.999 0.009 0.430
Social Phobia 21% (16) 12, 31 16% (12) 8, 24 0.454 0% (0) – 3% (1) −3, 9 0.999 0.002 0.104
Any Mood Disorder 75 3% (2) −1, 6 5% (4) 0, 11 0.625 33 0% (0) – 3% (1) −3, 9 0.999 0.999 0.999
Bipolar Disorder 0% (0) – 0% (0) – – 0% (0) – 0% (0) – – – –
Dysthymic Disorder 3% (2) −1,6 4% (3) −1, 9 0.999 0% (0) – 3% (1) −3, 9 0.999 0.999 0.999
Major Depressive Disorder 0% (0) – 1% (1) −1, 4 0.999 0% (0) – 0% (0) – 0.999 – 0.999
ADHD 75 37% (28) 26, 49 21% (16) 12, 31 0.004 33 3% (1) −3, 9 3% (1) −3, 9 0.999 < 0.001 0.020
Conduct disorder 75 0% (0) – 1% (1) −1, 4 0.999 33 0% (0) – 0% (0) – – – 0.999
Oppositional Deﬁance
Disorder
75 17% (13) 9, 26 15% (11) 6, 23 0.754 33 3% (1) −3, 9 3% (1) −3, 9 0.999 0.060 0.101
Any Psychotic disorder 75 0% (0) – 0% (0) – – 33 0% (0) −3, 9 0% (0) – – – –
Selective Mutism 75 4% (3) −1, 9 4% (3) −1, 9 0.999 33 3% (1) −3, 9 3% (1) −3, 9 0.999 0.999 0.551
Tic Disorder 75 5% (4) 0, 11 3% (2) −1, 6 0.625 33 0% (0) – 0% (0) – – 0.311 0.999
Trichtillomania 75 0% (0) – 0% (0) – – 33 0% (0) – 0% (0) – – – –
ASD screening (SCQ) 69 29% (22) 19, 40 38% (26) 26, 49 0.070 30 0% (0) – 0% (0) – – <0.001 <0.001
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T2. Individuals who had developed psychotic experiences by T2 (PE
(+)) had a relative deﬁcit of 0.50 SD in spatial working memory at T1
compared to the remainder of the sample (PE(-)) (Supplementary
Table 3; Fig. 2, Panel A). Furthermore, deterioration in sustained at-
tention was also associated with the emergence of psychotic experi-
ences (OR = 5.25, p = 0.021); 64% (7/11) of the PE(+) group ex-
hibited deterioration in sustained attention versus 25% (11/44) of the
PE(-) group. The sustained attention of the PE(+) group was 0.20 SD
above the PE(-) group at T1 but then dropped to 1.55 SD below the PE
(-) group at T2 (Supplementary Table 3; see Fig. 2, Panel B).
5.4. Psychiatric features
Psychiatric diagnosis at T1 and T2 was not associated with emer-
gence of psychotic experiences (Supplementary Table 4). When
symptom counts were analysed, individuals who developed psychotic
experiences at T2 had a greater total non-ASD symptom count (+6.41,
p = 0.046) as well as anxiety symptom count (+2.60, p = 0.029) at
T1, but this was no longer the case at T2 (Supplementary Table 4 and
Fig. 2 Panel D). Additionally, ADHD symptom schange was negatively
associated with the emergence of psychotic experiences (OR=0.54
(95%CI=0.30–0.97, p= 0.039) (see Supplementary Table 4 and Fig. 2
Panel C). We included total symptom count on the CAPA (non-ASD
symptomatology) in analyses, as previous studies on our cohort indicate
a high level of psychiatric comorbidity (Cunningham et al., 2018;
Niarchou et al., 2014) hence total count maybe better capture psy-
chiatric severity, and also total symptom count on the CAPA has con-
struct validity as total psychiatric symptom count as measured by the
CAPA has previously been associated with increased probability of
having used specialty mental health services (Angold and Costello,
2000).
A post-hoc analysis was conducted to investigate how much var-
iance the factors identiﬁed accounted for. A logistic regression was
conducted with spatial working memory saverage, sustained attention
deterioration, baseline anxiety symptoms and ADHD symptom schange as
predictors and emergence of psychotic experiences as the outcome. We
did not include baseline non-ASD symptoms as this variable is mathe-
matically related to baseline anxiety symptoms and ADHD symptom
schange. Complete data for spatial working memory saverage, sustained
attention deterioration, baseline anxiety symptoms and ADHD
symptom schange was available for 55 children with 22q11.2DS, of
which 11 had psychotic experiences. Nagelkerke r square was 0.353
(p= 0.006), indicating that the factors we identiﬁed accounted for
35.3% of the variance in psychotic experience outcome at T2. Only
sustained attention deterioration (p=0.037) and T1 anxiety symptoms
(p= 0.049) were found to be unique contributors in the regression
model. An important question is whether the factors identiﬁed re-
present processes that occur in the same individuals. To address this we
tested if the factors identiﬁed were associated with each other. Spatial
working memory ability saverage was found to be negatively correlated
with the presence of sustained attention deterioration (r=−0.315, p-
= 0.016), i.e. the lower an individual's spatial working memory ability,
the more likely an individual was to exhibit deterioration in sustained
attention. No other nominally signiﬁcant correlations were found be-
tween the four predictors.
6. Discussion
This study provides a detailed examination of the longitudinal
changes that occur in the crucial developmental period of early ado-
lescence in 22q11.2DS. The same measures were administered at both
time points and in cases and controls. Our study highlights that psy-
chotic experiences in this high-risk syndrome emerge at an early age.
Prevalence of subthreshold psychotic experiences increased in
22q11.2DS from 4% in childhood (T1) to 21% in early adolescence
(T2), and at T2 prevalence was elevated relative to control siblings
(3%). Hallucinatory phenomena particularly drove this increase. The
majority of psychotic experiences in early adolescence were only re-
ported by the child, highlighting that it is important for clinicians and
researchers to conduct screening interviews for psychotic phenomena
directly with children with 22q11.2DS in addition to interviewing the
caregiver.
Fig. 1. Psychiatric disorders in children with 22q11.2DS at T1 and T2 ADHD, Attention Deﬁcit Hyperactivity Disorder; ASD, Autism Spectrum Disorder; SCQ, Social
Communication Questionnaire. See Table 1 for full scores. *indicates signiﬁcant diﬀerence in prevalence (McNemar's p-value<0.05). Error bars represent the
standard error.
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This initial emergence of psychotic experiences was associated with
both neurocognitive and psychopathology factors. We did not ﬁnd IQ
ability or change in IQ to be related to the emergence of psychotic
experiences, however, there was a link with the speciﬁc neurocognitive
domains. Deﬁcits in the spatial working memory aspect of executive
function and deterioration in sustained attention were found to be as-
sociated with the emergence of psychotic experiences. Furthermore,
these two processes were correlated with each other indicating that
attention-executive function may be the initial neurocognitive domain
altered in those who go on to develop psychotic disorder. Though it
should be noted that not all our measures of executive function were
associated with emergence of psychotic experiences, indicating that
speciﬁc eﬀects exist within broadly deﬁned domains such as executive
function.
There was high psychiatric morbidity in childhood and early ado-
lescence in 22q11.2DS, prevalence of any psychiatric disorder, any non-
ASD psychiatric disorder, any anxiety disorder, ADHD and putative
ASD was elevated compared to control siblings. T1 non-ASD psychiatric
symptomatology was found to be greater in children with 22q11.2DS
who later developed psychotic experiences compared to children with
22q11.2DS who did not. Our measure of non-ASD psychiatric sympto-
matology has construct validity as total psychiatric symptom count as
measured by the CAPA has previously been associated with increased
probability of having used specialty mental health services (Angold and
Costello, 2000). Furthermore, T1 level of anxiety symptoms was greater
in children who later developed psychotic experiences.
The prevalence of ADHD decreased between T1 and T2, replicating
previous ﬁndings for 22q11.2DS (Antshel et al., 2013) and idiopathic
ADHD (Langley et al., 2010). Change in ADHD symptomatology was
associated with the emergence of psychotic experiences at T2. This
ﬁnding could be explained by diagnostic overshadowing, our measures
of ADHD symptomatology and psychotic experiences may be indexing
the same underlying trait that is interpreted diﬀerently with develop-
ment.
Overall the neurocognitive and psychopathology factors we identi-
ﬁed were found to account for 35.3% of the variance in psychotic ex-
perience outcome. Baseline anxiety symptoms and deterioration in
sustained attention are particularly unique contributors. Future studies
need to explore what factors explain the remaining variance.
6.1. Comparison to previous 22q11.2DS studies
Our study provides insights into the period of early adolescence in
22q11.2DS, and our sample size (n=75) and time between assess-
ments is comparable to previous longitudinal studies of 22q11.2DS
(Antshel et al., 2010; Tang and Gur, 2017). Previous longitudinal stu-
dies have identiﬁed altered development in the attention-executive
domain as contributing to the development of psychosis spectrum
outcomes in 22q11.2DS (Hooper et al., 2013; Maeder et al., 2016; Tang
and Gur, 2017). Our study highlights that these cognitive processes are
occurring during early adolescence and are associated with the initial
emergence of phenomena. Attention-executive deﬁcits may be a do-
main that cuts across several neuropsychiatric features of 22q11.2DS,
and may be more predictive of psychosis than individual neu-
ropsychiatric features (Baker and Vorstman, 2012).
We do not ﬁnd IQ to be related to emergence of psychotic
Fig. 2. Relation of cognitive and psychopathology factors with psychotic experiences These graphs show the average trajectories of individuals with 22q11.2DS with
and without psychotic experiences. Values for A and B can be found in Supplementary Table 3. Values for C and D can be found in Supplementary Table 4. Error bars
represent the standard error.
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experiences, however this may be because our study examines an ear-
lier age period, when IQ trajectories are only hypothesised to begin to
diverge in those who later develop psychosis. This may indicate that
changes in global cognitive ability (IQ) may be secondary to initial
changes in speciﬁc neurocognitive domains. Indeed other authors have
hypothesised that executive function decline may contribute to VIQ
decline seen in 22q11.2DS (Antshel et al., 2016). It brings into question
whether IQ decline is a correlate of psychosis development rather than
being truly antecedent. Discrepancy in ﬁndings could also reﬂect
methodological diﬀerences. Our study used the WASI IQ test version,
whereas previous studies have used the Wechsler Intelligence Scale for
Children (WISC) which contains subtests that measure working memory
and processing speed, therefore the WISC maybe more sensitive to
neurocognitive domains that decline in 22q11.2DS than the WASI.
Additionally, our study has a relatively narrow time gap which allows
the detection of dynamic changes in cognitive and psychiatric devel-
opment that may have otherwise been averaged out in studies with a
wider time gap. However, a narrow time gap may not be as suitable to
detect subtle changes that occur over a longer period.
Presence of anxiety at baseline has previously been identiﬁed as a
risk factor for developing psychosis in 22q11.2DS (Gothelf, Feinstein,
2007a; Gothelf et al., 2013; Tang and Gur, 2017). This is in agreement
with our ﬁnding that baseline anxiety symptom count is higher in those
who later develop psychotic experiences. We did not ﬁnd evidence that
ASD (as screened by the SCQ) is related to emergence of psychotic
phenomena, a ﬁnding consistent with previous 22q11.2DS studies that
have found that ASD and psychosis are independent consequences of
the deletion (Fiksinski et al., 2017; Vorstman et al., 2013).
6.2. Comparison to previous studies of psychotic phenomena in individuals
without 22q11.2DS
Our ﬁndings are consistent with that observed in individuals with
psychosis spectrum outcomes without 22q11.2DS. Several studies have
implicated attention-executive deﬁcits in the development of psychotic
experiences and psychotic disorder in the general population (Niarchou
et al., 2015; Reichenberg et al., 2010; Rossi et al., 2016). More gen-
erally, abnormalities of information processing and attention have
played a central role in theories of psychosis since the time of Kraepelin
and Bleuler (Braﬀ, 1993). Also an increasing number of studies provide
evidence suggesting that heightened anxiety is important in both the
development of psychosis and maintaining psychosis (Hall, 2017).
Overall this supports the conclusion that 22q11.2DS is a representative
model for characterising childhood development associated with
emergence of psychotic spectrum outcomes.
6.3. Limitations
Although we had the advantage of a longitudinal design and con-
current neurocognitive and psychiatric assessment at all time points, it
is diﬃcult to infer direction of eﬀect with some of our ﬁndings. For
instance, we are unable to unpick whether deterioration in sustained
attention is a cause or correlate of the emergence of psychotic experi-
ences. Not all children understood instructions for all cognitive tasks
leading to missing data, and therefore ﬁndings may not be re-
presentative of children with 22q11.2DS and severe cognitive deﬁcits.
Our study is one of the few longitudinal studies that has examined
neurocognitive ability beyond IQ, focusing on executive function, at-
tention and processing speed. However we did not examine socio-
emotional cognition, an important domain impaired in 22q11.2DS (Gur
et al., 2014). We have argued that assessing the factors associated with
the emergence of psychotic experiences may give insight into the initial
phase of psychosis emergence, however it is important to emphasise
that psychotic experiences, like other risk factors for psychotic disorder
development, are not deterministic of developing full-blown psychotic
disorder.
7. Conclusions
Early adolescence is the period of development in 22q11.2DS where
early subthreshold psychotic experiences emerge. We identiﬁed neu-
rocognitive and psychopathology factors associated with the emergence
of psychotic experiences, and our ﬁndings suggest that the attention-
executive domain and anxiety level are the ﬁrst to be disrupted in the
disease process that leads to psychotic disorder development in this
high-risk group. Further work is needed to bring together the strands of
22q11.2DS research that have focused on diﬀerent stages of psychosis
development. Characterisation of these stages will give greater under-
standing on which factors contribute to disease progression and which
are correlates of disease progression. 22q11.2DS is a powerful model to
explore and understand the development of psychosis. Our ﬁndings
may also have implications for psychosis risk in other high-risk popu-
lations.
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